Literature DB >> 21976462

Relapse versus reinfection: surveillance of Clostridium difficile infection.

Mini Kamboj1, Perminder Khosa, Anna Kaltsas, N Esther Babady, Crystal Son, Kent A Sepkowitz.   

Abstract

Molecular typing was used to examine surveillance definitions for recurrent Clostridium difficile-associated diarrhea. Among 102 patients, 85 had a second episode within 8 weeks, 88% of which were relapses. Of 49 second episodes occurring after > 8 weeks, 65% were relapses. Categorization of a recurrent episode occurring after >8 weeks as a new infection may misrepresent the majority of episodes for surveillance.

Entities:  

Mesh：

Year:  2011        PMID： 21976462      PMCID： PMC3246877          DOI： 10.1093/cid/cir643

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

3.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications.

Authors:  Ramsey M Dallal; Brian G Harbrecht; Arthur J Boujoukas; Carl A Sirio; Linda M Farkas; Kenneth K Lee; Richard L Simmons
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism.

Authors:  S Johnson; A Adelmann; C R Clabots; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

6.  Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing.

Authors:  P Bidet; F Barbut; V Lalande; B Burghoffer; J C Petit
Journal:  FEMS Microbiol Lett       Date:  1999-06-15       Impact factor: 2.742

7.  Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea.

Authors:  R Alonso; S Gros; T Peláez; D García-de-Viedma; M Rodríguez-Créixems; E Bouza
Journal:  J Hosp Infect       Date:  2001-06       Impact factor: 3.926

8.  Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea.

Authors:  Yajarayma Tang-Feldman; Susan Mayo; Joseph Silva; Stuart H Cohen
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection.

Authors:  Ajay K Sethi; Wafa N Al-Nassir; Michelle M Nerandzic; Greg S Bobulsky; Curtis J Donskey
Journal:  Infect Control Hosp Epidemiol       Date:  2010-01       Impact factor: 3.254

10.  Relapse versus reinfection with Clostridium difficile.

Authors:  G L O'Neill; M H Beaman; T V Riley
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451
View more
  27 in total

1.  Sustained clinical response as an endpoint in treatment trials of Clostridium difficile-associated diarrhea.

Authors:  Stuart Johnson; Dale N Gerding; Thomas J Louie; Nancy M Ruiz; Sherwood L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

2.  Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Authors:  Anna M Seekatz; Emily Wolfrum; Christopher M DeWald; Rosemary K B Putler; Kimberly C Vendrov; Krishna Rao; Vincent B Young
Journal:  Anaerobe       Date:  2018-05-31       Impact factor: 3.331

3.  Differences in the Molecular Epidemiology and Antibiotic Susceptibility of Clostridium difficile Isolates in Pediatric and Adult Patients.

Authors:  Larry K Kociolek; Dale N Gerding; James R Osmolski; Sameer J Patel; David R Snydman; Laura A McDermott; David W Hecht
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Environmental Contamination in Households of Patients with Recurrent Clostridium difficile Infection.

Authors:  Megan K Shaughnessy; Aleh Bobr; Michael A Kuskowski; Brian D Johnston; Michael J Sadowsky; Alexander Khoruts; James R Johnson
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

5.  Clinical characteristics of patients who test positive for Clostridium difficile by repeat PCR.

Authors:  Daniel A Green; Brie Stotler; Dana Jackman; Susan Whittier; Phyllis Della-Latta
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

6.  Association of relapse of Clostridium difficile disease with BI/NAP1/027.

Authors:  Jane W Marsh; Rangolee Arora; Jessica L Schlackman; Kathleen A Shutt; Scott R Curry; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

Review 7.  Recent Issues in Pediatric Clostridium difficile Infection.

Authors:  Jason A Clayton; Philip Toltzis
Journal:  Curr Infect Dis Rep       Date:  2017-11-07       Impact factor: 3.725

8.  Phase 1 Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Doses of DS-2969b, a Novel GyrB Inhibitor, in Healthy Subjects.

Authors:  Alexander G Vandell; Satoshi Inoue; Justin Dennie; Yasuo Nagasawa; Roohi Gajee; Joe Pav; George Zhang; Cynthia Zamora; Nobuhisa Masuda; Giorgio Senaldi
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

9.  Role of Coinfecting Strains in Recurrent Clostridium difficile Infection.

Authors:  Janet Sun; Tracy Mc Millen; N Esther Babady; Mini Kamboj
Journal:  Infect Control Hosp Epidemiol       Date:  2016-08-30       Impact factor: 3.254

10.  Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial.

Authors:  Anna Barker; Megan Duster; Susan Valentine; Laurie Archbald-Pannone; Richard Guerrant; Nasia Safdar
Journal:  Contemp Clin Trials       Date:  2015-07-22       Impact factor: 2.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.